KIDRON NADAV 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Apr 20, 2023
Insider Transaction Report
Form 4
KIDRON NADAV
DirectorPresident and CEO
Transactions
- Award
Common Stock
2023-04-17+279,000→ 1,332,098 total
Holdings
- 126,000(indirect: By wholly-owned corporation)
Common Stock
Footnotes (1)
- [F1]Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 23,250 over a three year period starting May 1, 2023. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.